[1] 陈翀昊,王广燕,苏衡,等.瑞舒伐他汀与阿托伐他汀对早发冠心病急性心肌梗死患者的近期疗效[J].中国临床药理学杂志,2013,29(2):126-128. [2] 张新梅,胡允兆,陈样新等.急性心肌梗死住院死亡危险因素分析[J]. 广东医学,2013,34(2):260-263。 [3] 赵睿,卢前微,杨蕊,等.急性心肌梗死患者院外治疗依从性及远期生存状况分析[J].中南大学学报(医学版),2016,41(2):163-168. [4] TAO T, WANG H, WANG S X, et al. Long-term outcomes of high-risk elderly male patients with multivessel coronary disease: optimal medical therapy versus revascularization[J]. J Geriatr Cardiol,201,13(2):152-157. [5] ABDULBAKI A, MODI K, TAKALKAR A M. Relative merits of single-photon emission computed tomography and pet perfusion imaging: a cardiologist's view[J]. PET Clin,2011,6(4):431-439. [6] SCHLOTTER F, DE WAHA S, EITEL I, et al. Interventional post-myocardial infarction ventricular septal defect closure: a systematic review of current evidence[J]. Euro Intervention, 2016,12(1):94-102. [7] 张宏,姚威,罗平,等.瑞舒伐他汀用于直接经皮冠状动脉介入治疗的疗效观察[J].中国药业,2013,22(5):77-78. [8] 李拥军.经皮冠状动脉介入治疗的并发症[J].中国介入心脏病学杂志,2016,24(1):55-57. [9] 史利锋,林平.经皮冠状动脉介入治疗患者术后心脏不良事件的发生情况及影响因素[J].中华护理杂志,2015,50(12):1449-1453. [10] FAM J M, FELIX C, van GEUNS R J, et al. Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study[J].Euro Intervention,2016,12(1):30-37. [11] ZHENG J, CHENG J, ZHANG Q,et al. Association between glycosylated hemoglobin level and cardiovascular outcomes in diabetic patients after percutaneous coronary intervention[J]. Medicine, 2016,95(19):e3696. [12] 赵祥淘,杨松,陈燕春,等.青年人急性心肌梗死危险因素及冠脉病变特点[J].山东医药,2014,54(7):45-47. [13] 张北玉,刘灿君,孙爽,等.瑞舒伐他汀早期干预治疗对急性心肌梗死患者行急诊经皮冠状动脉介入治疗中冠状动脉血流的影响[J].中国循环杂志,2013,28(4):270-273. [14] AN S G, LEE H W. Percutaneous coronary intervention for a recent myocardial infarction with an anomalous right coronary artery arising from the mid left anterior descending coronary artery[J]. Chin Med J (Engl),2016,129(10):1259-1260. [15] LASSEN J F, HOLM N R, BANNING A, et al. Percutaneous coronary intervention for coronary bifurcation disease: 11th consensus document from the European Bifurcation Club[J]. Euro Intervention,2016,12(1):38-46. [16] DANGAS G D, SCHOOS M M, STEG P G, et al. Early stent thrombosis and mortality after primary percutaneous coronary intervention in st-segment-elevation myocardial infarction: a patient-level analysis of 2 randomized trials[J]. Circ Cardiovasc Interv,2016,9(5):e003272. |